中国药房2017，Vol.28Issue(25)：3464-3467,4.DOI:10.6039/j.issn.1001-0408.2017.25.03
德国、日本和我国台湾地区药品价格规制经验及启示
Experience and Enlightenment of Drug Price Regulation in Germany,Japan and Taiwan Area of China
摘要
Abstract
OBJECTIVE:To provide reference for improving the drug price regulation policy in China. METHODS:Literature research,system comparison and other methods were used to summarize the commonalities and characteristics of drug price regula-tion policy in Germany,Japan and Taiwan area of China,and the successful experience was learned. RESULTS & CONCLU-SIONS:Drug price management in Germany,Japan and Taiwan area of China has their own characteristics. Germany conducted reference price system and new drug pricing mechanism,which was the first country to introduce the reference price system. Japan granted price premiums to innovative drugs,decreased pricing for generic drugs and adjusted drug price again. And Taiwan area of China classified and grouped differential pricing to encourage competition negotiation and regularly investigated drug prices and pric-ing. Germany,Japan and Taiwan area regard medicare pay price as core of drug price management,adopt comprehensive means to regulate the drug price,and pay attention to the monitoring and regular adjustment of market price as well. Price negotiation,phar-macoeconomics and multiple pricing methods are broadly used. Value-based drug pricing system is new trend of price policy re-form. It can be used for reference to improve the drug price regulation system in China.关键词
药品价格/德国/日本/台湾地区/价格规制Key words
Drug price/Germany/Japan/Taiwan area/Price regulation分类
医药卫生引用本文复制引用
陈敬,赵熙子,赵亮,史录文..德国、日本和我国台湾地区药品价格规制经验及启示[J].中国药房,2017,28(25):3464-3467,4.基金项目
国家自然科学基金青年项目(No. 71503017) （No. 71503017）
